- Manufacturer : Abbott India Ltd.
- Composition : Prochlorperazine 12.5mg
- Generally Prescribed For : Nausea, Vomiting , Schizophrenia, Anxiety
- Estimated Price : ₹14.00 For 1ml Vial
table of contents
Table of Contents
Table of Contents
Uses of Stemetil 12.5mg Injection
Stemetil 12.5mg Injection is used for the treatment or prevention of the following disease(s):
Nausea, Vomiting , Schizophrenia, Anxiety
Side effects of Stemetil 12.5mg Injection
The most common side effects of Stemetil 12.5mg Injection are – Blurred Vision, Dry Mouth, Nasal Congestion, Ocular Changes, Constipation, Epigastric Pain, Nausea, Vomiting
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while using Stemetil 12.5mg Injection
Do not use Stemetil 12.5mg Injection if you are allergic to – Prochlorperazine
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Stemetil 12.5mg Injection.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
How Stemetil 12.5mg Injection works
Stemetil 12.5mg Injection contains – Prochlorperazine
Prochlorperazine is thought to work by blocking the action of a chemical called dopamine which acts on the nervous system in the brain.
Dosage of Stemetil 12.5mg Injection
The dosage of Stemetil 12.5mg Injection depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Overdose of Stemetil 12.5mg Injection
If you forget to take a dose of Stemetil 12.5mg Injection, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
Interaction
Drug :- aluminum- or magnesium-containing antacids, antidiarrheals adsorbent: Possibly inhibited absorption of oral prochlorperazine amantadine, anticholinergics, antidyskinetics, antihistamines: Possibly intensified anticholinergic adverse effects, increased risk of prochlorperazine-induced hyperpyretic effect.
amphetamines: Decreased stimulant effect of amphetamines, decreased antipsychotic effect of prochlorperazine.
anticonvulsants: Lowered seizure threshold.
antithyroid drugs: Increased risk of agranulocytosis.
apomorphine: Possibly decreased emetic response to apomorphine, additive CNS depression.
appetite suppressants: Possibly antagonized anorectic effect of appetite suppressants.except for phenmetrazine.
astemizole, cisapride, disopyramide, erythromycin, pimozide, probucol, procainamide: Additive QT interval prolongation, increased risk of ventricular tachycardia.
beta blockers: Increased risk of additive hypotensive effects, irreversible retinopathy, arrhythmias, and tardive dyskinesia.
bromocriptine: Decreased effectiveness of bromocriptine.
CNS depressants: Additive CNS depression.
dopamine: Possibly antagonized peripheral vasoconstriction high doses of dopamine.
ephedrine, epinephrine: Decreased vasopressor effects of these drugs.
hepatotoxic drugs: Increased risk of hepatotoxicity.
hypotension-producing drugs: Possibly severe hypotension with syncope.
levodopa: Inhibited antidyskinetic effect of levodopa.
lithium: Reduced absorption of oral prochlorperazine, increased lithium excretion, increased extrapyramidal effects, possibly masking of early symptoms of lithium toxicity. MAO inhibitors, maprotiline, tricyclic antidepressants: Possibly prolonged and intensified anticholinergic and sedative effects, increased antidepressant level, inhibited prochlorperazine metabolism, increased risk of neuroleptic malignant syndrome.
mephentermine: Possibly antagonized antipsychotic effect of prochlorperazine and vasopressor effect of mephentermine.
metrizamide: Increased risk of seizures.
opioid analgesics: Increased risk of CNS and respiratory depression, orthostatic hypotension, severe constipation, urine retention.
ototoxic drugs: Possibly masking of some symptoms of ototoxicity, such as dizziness, tinnitus, and vertigo.
phenytoin: Possibly inhibited phenytoin.
metabolism, increased risk of phenytoin toxicity.
thiazide diuretics: Possibly potentiated hyponatremia and water intoxication.
Activity :- alcohol use: Additive CNS depression.
